Status:
UNKNOWN
An Update on Intracerebral Hemorrhage
Lead Sponsor:
Shifa Clinical Research Center
Collaborating Sponsors:
Shifa International Hospital
Chongqing Medical University
Conditions:
Intracerebral Hemorrhage
Stroke
Eligibility:
All Genders
18+ years
Brief Summary
The intracerebral hemorrhage study is a multicenter , combination of prospective and retrospective observational cohort study led by Dr. Muhammad Junaid Akram, PhD scholar at Chongqing Medical Univers...
Detailed Description
The study will be used to address the several key issues related to intracerebral hemorrhage. The demographics, scores based upon disease severity , mRS, GCS, NIHSS scores will be recorded at baseline...
Eligibility Criteria
Inclusion
- Age \> 18 years Patients willing to participate via signing a consent form' Patients diagnosed with CT-Confirmed spontaneous intracerebral hemorrhage (ICH) Patients willing to participate in the follow up assessment
Exclusion
- Not willing to participate Secondary ICH to hemorrhagic infarction or tumor bleeding etc. Traumatic ICH
Key Trial Info
Start Date :
March 17 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2022
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04783922
Start Date
March 17 2021
End Date
February 1 2022
Last Update
April 13 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shifa Tameer e Millat University
Islamabad, Pakistan, 46000